Reiter Paul L, Gupta Kunal, Brewer Noel T, Gilkey Melissa B, Katz Mira L, Paskett Electra D, Smith Jennifer S
Authors' Affiliations: Division of Cancer Prevention and Control, College of Medicine; Comprehensive Cancer Center; College of Public Health, The Ohio State University, Columbus, Ohio; UNC Gillings School of Global Public Health; and Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.
Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):742-54. doi: 10.1158/1055-9965.EPI-13-0979. Epub 2014 Mar 14.
Hispanic females have the highest cervical cancer incidence rate of any racial or ethnic group in the United States, yet relatively little research has examined human papillomavirus (HPV) vaccination among this fast-growing population. We examined HPV vaccination among a national sample of Hispanic adolescent females.
We analyzed provider-verified vaccination data from the 2010-2011 National Immunization Survey-Teen for Hispanic females ages 13 to 17 years (n = 2,786). We used weighted logistic regression to identify correlates of HPV vaccine initiation (receipt of one or more doses), completion (receipt of three doses), and follow-through (receipt of three doses among those who initiated the series).
HPV vaccine initiation was 60.9%, completion was 36.0%, and follow-through was 59.1%. Initiation and completion were more common among older daughters and those whose parents had received a provider recommendation to vaccinate (all P < 0.05). Completion was less common among daughters who had moved from their birth state (P < 0.05). All vaccination outcomes were less common among daughters without health insurance (all P < 0.05). Vaccination did not differ by parents' preferred language (all P > 0.05), although intent to vaccinate was higher among Spanish-speaking parents (P < 0.01). Spanish-speaking parents were more likely to indicate lack of provider recommendation (20.2% vs. 5.3%) and cost (10.9% vs. 1.8%) as main reasons for not intending to vaccinate (both P < 0.05).
Many Hispanic females have not received HPV vaccine. Several factors, including provider recommendation and health insurance, are key correlates of vaccination.
HPV vaccination programs targeting Hispanics are needed and should consider how potential barriers to vaccination may differ by preferred language.
在美国，西班牙裔女性的宫颈癌发病率在所有种族或族裔群体中最高，但针对这一快速增长人群的人乳头瘤病毒（HPV）疫苗接种情况的研究相对较少。我们对全国范围内的西班牙裔青少年女性样本进行了HPV疫苗接种情况调查。
我们分析了2010 - 2011年全国青少年免疫调查中13至17岁西班牙裔女性（n = 2786）经提供者核实的疫苗接种数据。我们使用加权逻辑回归来确定HPV疫苗起始接种（接种一剂或多剂）、完成接种（接种三剂）以及后续接种（在开始接种系列的人群中接种三剂）的相关因素。
HPV疫苗起始接种率为60.9%，完成接种率为36.0%，后续接种率为59.1%。在年龄较大的女儿以及父母收到提供者接种建议的女儿中，起始接种和完成接种更为常见（所有P < 0.05）。在已搬离其出生州的女儿中，完成接种的情况较少见（P < 0.05）。在没有医疗保险的女儿中，所有疫苗接种结果都较少见（所有P < 0.05）。疫苗接种情况在父母的首选语言方面没有差异（所有P > 0.05），尽管说西班牙语的父母接种意愿更高（P < 0.01）。说西班牙语的父母更有可能指出缺乏提供者建议（20.2%对5.3%）和费用（10.9%对1.8%）是不打算接种的主要原因（两者P < 0.05）。
许多西班牙裔女性尚未接种HPV疫苗。包括提供者建议和医疗保险在内的几个因素是疫苗接种的关键相关因素。
需要针对西班牙裔人群的HPV疫苗接种项目，并且应该考虑到接种的潜在障碍可能因首选语言而有所不同。
